Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Cáncer de mama
1.
2. PROLIFERACION MALIGNA DE CELULAS
EPITELIALES QUE REVISTEN
CONDUCTOS O LOBULILLOS
RELACIONADOS CON MUTACION EN
LINEA GERMINAL 10%
SIND DE LI-FRAUMENI (P53):SARCOMAS,
OSTEOSARCOMA, CA DE MAMA,
LEUCEMIA, TUMOR DE CEREBRO.
3. BRCA1(GEN SUPRESOR) 17q21; BRCA2:
13q12
GEN MUTADO: 60 A 80 % CA DE MAMA Y
33% CA DE OVARIO
PUEDE HABER MUTACION DE LINEA
GERMINAL DE GENES BRCA1 Y 2
PERDIDA DE HETEROCIGOSIDAD DE
BRCA1 Y 2 EN CASOS ESPORADICOS
4. Figure 1 from A Rudolph
British Journal of Cancer Advance Online Publication
12 January 2016 doi:10.1038/bjc.2015.439
5. MENARQUIA TEMPRANA
MENOPAUSIA TARDIA
DIETA: CONSUMO GRASAS SATURADAS
OBESIDAD: INCREMENTO DE ACTIVIDAD
DE AROMATASA EN TEJIDO ADIPOSO
CONSUMO DE ALCOHOL
TERAPIA DE RESTITUCION HORMONAL
6.
7.
8. GRUPO N ER TUMOR RECOMENDACION
PREMENOPAUSIA POS ANY ANY QT M/D + TAM (ER+) +
TRASTUZUMAB
(HER2+)
PREMENOPAUSIA NEG ANY >2 CM O 1 A
2 CM FACT P
(-)
QT M/D + TAM (ER+) +
TRASTUZUMAB
(HER2+)
POSTMENOPAUSIA POS NEG ANY QT M/D +
TRASTUZUMAB
(HER2+)
POSTMENOPAUSIA POS POS ANY ARO INH + TAM CON
O SIN QT +
TRASTUZUMAB
(HER2+)
POSTMENOPAUSIA NEG POS >2 CM O 1-2
CM FACT P(-)
ARO INH + TAM +
TRASTUZUMAB
(HER2+)
POSTMENOPAUSIA NEG NEG >2 CM O 1-2 QT M/D +
9. 0
I
II A
IIB
IIIA
IIIB
IV
99%
92%
82%
65%
47%
44%
14%
Several approaches exist to target Eph receptors. Kinase inactivating strategies include kinase inhibitors or blocking peptides or antibodies. Kinase activating strategies include ligand stimulation, activating antibodies or ligand peptide mimetics Strategies to deliver toxic payloads following receptor activation and internalisation include coupling of cytotoxic agents or radionuclides to Eph monoclonal antibodies.
Several approaches exist to target Eph receptors. Kinase inactivating strategies include kinase inhibitors or blocking peptides or antibodies. Kinase activating strategies include ligand stimulation, activating antibodies or ligand peptide mimetics Strategies to deliver toxic payloads following receptor activation and internalisation include coupling of cytotoxic agents or radionuclides to Eph monoclonal antibodies.